Explore key insights from Veracyte's Q1 2024 earnings, including significant revenue growth, testing volume records, and strategic expansions.
Robust Growth in Testing Revenue Drives Positive Financial Outcomes
SOUTH SAN FRANCISCO, Calif., May 07, 2024--Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the first quarter ended March 31, 2024.